\n\n125 micrograms \/ 62.5 micrograms inhalation powder, hard capsules 125 micrograms \/ 127.5 micrograms inhalation powder, hard capsules 125 micrograms \/ 260 micrograms inhalation powder, hard capsules indacaterol \/ mometasone furoate (indacaterol \/ mometasone. Fur).<\/p>\n\n\n\n
What Atectura Breezhaler is and how it works<\/strong><\/p>\n\n\n\n Atectura Breezhaler contains two active substances: indacaterol and mometasone furoate. Indacaterol belongs to a group of medicines called bronchodilators. This relaxes the muscles in the small airways in the lungs. This helps to dilate the airways so that it is easier for the air to get in and out of the lungs. If the medicine is taken regularly, it helps to keep the small airways continuously open. Mometasone furoate belongs to a group of medicines called corticosteroids (or steroids ). Corticosteroids reduce swelling and irritation ( inflammation ) in the small airways in the lungs and thus gradually reduce breathing problems. Corticosteroids also help prevent asthma attacks. What Atectura Breezhaler is used for<\/strong><\/p>\n\n\n\n Atectura Breezhaler is regularly used to treat asthma in adults and adolescents (from 12 years of age). Asthma is a serious, chronic lung disease that involves the muscles around the small airways contracting ( bronchoconstriction ) and becoming inflamed. The symptoms come and go and can be shortness of breath, wheezing, tightness in the chest, and cough. Use Atectura Breezhaler every day as prescribed by your doctor, not only when you have difficulty breathing or have other asthma symptoms. That way, you can have good control over your asthma. This medicine should not be used to relieve a sudden attack of shortness of breath or wheezing. Ask your doctor if you are wondering how Atectura Breezhaler works or why the medicine has been prescribed for you. Follow your doctor’s instructions carefully.<\/p>\n\n\n\n Talk to your doctor, pharmacist, or nurse before<\/strong> using Atectura Breezhaler if any of the following apply to you:<\/p>\n\n\n\n During treatment with Atectura Breezhaler<\/strong><\/p>\n\n\n\n Stop using this medicine and seek immediate medical attention<\/strong> if you have any of the following:<\/p>\n\n\n\n Do not give this medicine to children under 12 years of age, as it has not been studied in this age group.<\/p>\n\n\n\n Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. It is especially important that you tell your doctor or pharmacist if you are taking:<\/p>\n\n\n\n If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine. Your doctor will tell you if you can take Atectura Breezhaler or not.<\/p>\n\n\n\n This medicine is unlikely to affect your ability to drive or use machines.<\/p>\n\n\n\n This medicine contains approximately 25 mg of lactose per capsule. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine<\/p>\n\n\n\n Always use this medicine exactly as your doctor or pharmacist has told you. Ask your doctor or pharmacist if you are unsure. How much Atectura Breezhaler to inhale<\/strong><\/p>\n\n\n\n The Atectura Breezhaler capsules are available in three different strengths. The doctor decides which is best for you. The usual dose is to inhale the contents of one capsule daily. You only need to inhale once a day. Do not use more than your doctor prescribed. Use Atectura Breezhaler every day, even if you do not experience any problems with your asthma. When to inhale Atectura Breezhaler<\/strong><\/p>\n\n\n\n Inhale Atectura Breezhaler at the same time each day. It helps keep your symptoms under control around the clock. It also makes it easier to remember to take the medicine. How to inhale Atectura Breezhaler<\/strong><\/p>\n\n\n\n If your asthma does not improve or you get worse after starting Atectura Breezhaler, talk to your doctor.<\/p>\n\n\n\n If you have inhaled too much of this medicine, contact your doctor or hospital immediately for advice. You may need medical attention.<\/p>\n\n\n\n If you forget to inhale a dose at the usual time, inhale a dose as soon as possible that day. Then inhale the next dose at the usual time the next day. Do not inhale two doses on the same day.<\/p>\n\n\n\n Do not stop using Atectura Breezhaler unless your doctor tells you to. Your asthma symptoms may return if you stop using the medicine. If you have any further questions on the use of this product, ask your doctor or pharmacist.<\/p>\n\n\n\n Like all medicines, this medicine can cause side effects, although not everybody gets them. Some side effects can be serious<\/strong><\/p>\n\n\n\n Stop using Atectura Breezhaler and seek medical attention immediately if you get any of the following: Common:<\/strong> may affect up to 1 in 10 users<\/p>\n\n\n\n Uncommon:<\/strong> may affect up to 1 in 100 people<\/p>\n\n\n\n Other side effects are<\/strong><\/p>\n\n\n\n Other side effects that may occur are listed below. If these side effects get serious, talk to your doctor, pharmacist, or nurse. Very common:<\/strong> may affect more than 1 user in 10<\/p>\n\n\n\n Common:<\/strong> may affect up to 1 in 10 users<\/p>\n\n\n\n Uncommon:<\/strong> may affect up to 1 in 100 people<\/p>\n\n\n\n Reporting of side effects<\/em><\/p>\n\n\n\n If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Medical Products Agency, www.lakemedelsverket.se. By reporting side effects, you can help increase drug safety information. <\/p>\n\n\n\n Atectura Breezhaler 125 micrograms \/ 62.5 micrograms<\/strong><\/p>\n\n\n\n Each capsule contains 173 micrograms indacaterol acetate (equivalent to 150 micrograms indacaterol) and 80 micrograms of mometasone furoates. Each dose delivered (the dose leaving the mouthpiece of the inhaler) corresponds to 125 micrograms indacaterol and 62.5 micrograms mometasone furoates. Atectura Breezhaler 125 micrograms \/ 127.5 micrograms<\/strong><\/p>\n\n\n\n Each capsule contains 173 micrograms indacaterol acetate (equivalent to 150 micrograms indacaterol) and 160 micrograms mometasone furoates. Each dose delivered (the dose leaving the inhaler mouthpiece) corresponds to 125 micrograms indacaterol and 127.5 micrograms mometasone furoates. Atectura Breezhaler 125 micrograms \/ 260 micrograms<\/strong><\/p>\n\n\n\n Each capsule contains 173 micrograms indacaterol acetate (equivalent to 150 micrograms indacaterol) and 320 micrograms mometasone furoates. Each dose delivered (the dose leaving the inhaler mouthpiece) is equivalent to 125 micrograms indacaterol and 260 micrograms mometasone furoate.<\/p>\n\n\n\n This pack contains an inhaler together with blister capsules. The capsules are transparent and contain a white powder.<\/p>\n\n\n\n Pack sizes:<\/p>\n\n\n\n Pack of 10 x 1 or 30 x 1 hard capsules and 1 inhaler.<\/p>\n\n\n\n Multipack consisting of 3 cartons, with 30 x 1 hard capsules and 1 inhaler in each carton.<\/p>\n\n\n\n Multipack consisting of 15 cartons, with 10 x 1 hard capsules and 1 inhaler in each carton. Not all pack sizes may be available in your country.<\/p>\n\n\n\n Marketing Authorisation Holder<\/strong><\/p>\n\n\n\n Novartis Europharm Limited<\/p>\n\n\n\n Vista Building<\/p>\n\n\n\n Elm Park, Merrion Road<\/p>\n\n\n\n Dublin 4<\/p>\n\n\n\n Ireland Manufacturer<\/strong><\/p>\n\n\n\n Novartis Pharma GmbH<\/p>\n\n\n\n Roonstra\u00dfe 25<\/p>\n\n\n\n D-90429 Nuremberg<\/p>\n\n\n\n Germany Novartis Pharmac\u00e9utica, SA<\/p>\n\n\n\n Ronda de Santa Maria, 158<\/p>\n\n\n\n 08210 Barber\u00e0 del Vall\u00e9s (Barcelona)<\/p>\n\n\n\n Spain Contact the representative of the marketing authorization holder to find out more about this medicine:<\/p>\n\n\n\n Atectura Breezhaler contains two active substances: indacaterol and mometasone furoate.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2201,2200],"tags":[9909,9913,4537,4539,9912,9916,9911,9915,9910,9914,9917],"class_list":["post-5633","post","type-post","status-publish","format-standard","hentry","category-a","category-medicines","tag-atectura-breezhaler","tag-indacaterol","tag-mometasone-furoate","tag-mometasone-furoate-side-effects","tag-side-effects-of-atectura-breezhaler","tag-side-effects-of-indacaterol","tag-what-atectura-breezhaler-is-used-for","tag-what-indacaterol-is-used-for","tag-what-is-atectura-breezhaler","tag-what-is-indacaterol","tag-what-mometasone-furoate-is-used-for"],"_links":{"self":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/comments?post=5633"}],"version-history":[{"count":5,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5633\/revisions"}],"predecessor-version":[{"id":12453,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5633\/revisions\/12453"}],"wp:attachment":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/media?parent=5633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/categories?post=5633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/tags?post=5633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n2. What you need to know before using Atectura Breezhaler<\/h2>\n\n\n\n
Do not use Atectura Breezhaler<\/h2>\n\n\n\n
Warnings and cautions<\/h2>\n\n\n\n
Children and young people<\/h2>\n\n\n\n
Other medicines and Atectura Breezhaler<\/h2>\n\n\n\n
Pregnancy, breastfeeding, and fertility<\/h2>\n\n\n\n
Driving and using machines<\/h2>\n\n\n\n
Atectura Breezehaler contains lactose<\/h2>\n\n\n\n
3. How to use Atectura Breezhaler<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nIf your symptoms do not improve<\/h2>\n\n\n\n
If you use more Atectura Breezhaler than you should <\/h2>\n\n\n\n
If you forget to use Atectura Breezhaler<\/h2>\n\n\n\n
If you stop using Atectura Breezhaler<\/h2>\n\n\n\n
<\/p>\n\n\n\n4. Possible side effects<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n5. How to store Atectura Breezhaler<\/h2>\n\n\n\n
6. Contents of the packaging and other information<\/h2>\n\n\n\n
Content declaration<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nWhat the medicine looks like and the contents of the pack<\/h2>\n\n\n\n
<\/p>\n\n\n\nMarketing Authorization Holder and Manufacturer<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nBelgium \/ Belgique \/ Belgien<\/strong>Novartis Pharma NVTel: +32 2 246 16 11<\/td> Lithuania<\/strong>SIA Novartis Baltics Lithuanian branchesTel: +370 5 269 16 50<\/td><\/tr> Bulgaria<\/strong>Novartis Bulgaria EOODTel: +359 2 489 98 28<\/td> Luxembourg \/ Luxemburg<\/strong>Novartis Pharma NVTel: +32 2 246 16 11<\/td><\/tr> Czech Republic<\/strong>Novartis sroTel: +420 225 775 111<\/td> Hungary<\/strong>Novartis Hungary Kft.Tel .: +36 1 457 65 00<\/td><\/tr> Denmark<\/strong>Novartis Healthcare A \/ STel: +45 39 16 84 00<\/td> Malta<\/strong>Novartis Pharma Services Inc.Tel: +356 2122 2872<\/td><\/tr> Germany<\/strong>Novartis Pharma GmbHTel: +49 911 273 0<\/td> The Netherlands<\/strong>Novartis Pharma BVTel: +31 88 04 52 111<\/td><\/tr> Eesti<\/strong>SIA Novartis Baltics Eesti subsidiaryTel: +372 66 30 810<\/td> Norway<\/strong>Novartis Norge ASTel: +47 23 05 20 00<\/td><\/tr> Greece<\/strong>Novartis (Hellas) AEBE:\u0397\u03bb: +30 210 281 17 12<\/td> Austria<\/strong>Novartis Pharma GmbHTel: +43 1 86 6570<\/td><\/tr> Spain<\/strong>Novartis Pharmac\u00e9utica, SATel: +34 93 306 42 00<\/td> Poland<\/strong>Novartis Poland Sp. z ooTel .: +48 22 375 4888<\/td><\/tr> France<\/strong>Novartis Pharma SASTel: +33 1 55 47 66 00<\/td> Portugal<\/strong>Novartis Farma – Pharmaceutical Products, SATel: +351 21 000 8600<\/td><\/tr> Croatia<\/strong>Novartis Hrvatska dooTel. +385 1 6274 220<\/td> Romania<\/strong>Novartis Pharma Services Romania SRLTel: +40 21 31299 01<\/td><\/tr> Ireland<\/strong>Novartis Ireland LimitedTel: +353 1 260 12 55<\/td> Slovenia<\/strong>Novartis Pharma Services Inc.Tel: +386 1 300 75 50<\/td><\/tr> Iceland<\/strong>Vistor hf.Phone: +354 535 7000<\/td> Slovak Republic<\/strong>Novartis Slovakia sroTel: +421 2 5542 5439<\/td><\/tr> Italy<\/strong>Novartis Farma SpATel: +39 02 96 54 1<\/td> Finland \/ Finland<\/strong>Novartis Finland OyPuh \/ Tel: +358 (0) 10 6133 200<\/td><\/tr> \u039a\u03cd\u03c0\u03c1\u03bf\u03c2<\/strong>Novartis Pharma Services Inc.:\u0397\u03bb: +357 22 690 690<\/td> <\/td><\/tr> Latvia<\/strong>SIA Novartis BalticsTel: +371 67 887 070<\/td> United Kingdom<\/strong>Novartis Pharmaceuticals UK Ltd.Tel: +44 1276 698370<\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"